drugset / Trial / NCT01271686

24-hour IOP-lowering Effect of 0.01% Bimatoprost

NCT01271686

Phase 4 Completed 16 enrolled University of California, San Diego
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the 24-hour IOP-lowering efficacy of 0.01% bimatoprost once daily in patients with glaucoma or ocular hypertension

Timeline

Start
2011-01
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.01 %